I
Incyte Corporation (INCY)
NMS – Real vaqt narxi. Valyuta: USD
99.13
-1.19 (-1.19%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
99.13
-1.19 (-1.19%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Incyte Corporation, biofarmatsevtik kompaniya, Qo'shma Shtatlar, Yevropa, Kanada va Yaponiyada terapevtik vositalarni kashf qilish, ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Kompaniya miyelofibroz (MF), haqiqiy polisitemiya va steroidlarga chidamli o'tkir ko'chma-xost kasalligini davolash uchun JAKAFI; surunkali miyeloid leykemiya va Filadelfiya xromosomasi-pozitiv o'tkir limfoblastik leykemiyani davolash uchun kinaza inhibitore ICLUSIG; diffuz katta B-hujayrali limfoma va follikulyar limfomani davolash uchun MONJUVI/ MINJUVI; surunkali ko'chma-xost kasalligini davolash uchun NIKTIMVOni taklif etadi. Shuningdek, u muhim trombitsitoz va MFni davolash uchun INCA033989; anti-mutant kalretikulin va mieloproliferativ neoplazmalarni (MPN) davolash uchun INCA035784; MPNlarni davolash uchun INCB160058; jarrohlik qilinmaydigan o't yo'llari saratoni, metastatik xolangiokarsinoma va mieloid/limfoid neoplazmalarni davolash uchun selektiv fibroblast o'sish omilining retseptor kinaz inhibitori PEMAZYRE; metastatik yoki takrorlanuvchi mahalliy rivojlangan Merkel hujayrali karsinomasi bilan og'rigan kattalarni davolash uchun ZYNYZni taqdim etadi. Kompaniyaning klinik bosqichdagi mahsulotlari tuxumdon saratoni uchun INCB123667; qattiq o'smalar uchun INCB161734; saraton kasalliklari uchun INCA33890; atopik dermatit, hidradenit suppurativa (HS) va prurigo nodularisni davolash uchun Ruxolitinib kremi; HS, nosimmetrik vitiligo, prurigo nodularis va astmani davolash uchun Povorcitinib; va fibrodysplasia ossificans progressivini davolash uchun INCB00928ni o'z ichiga oladi. U Novartis, Lilly va Syndax bilan hamkorlik va litsenziya shartnomalariga ega. Kompaniya o'z mahsulotlarini maxsus va chakana dorixonalar, shifoxona dorixonalari va distribyutorlarga sotadi. Kompaniya ilgari Incyte Genomics Inc nomi bilan tanilgan va 2003 yil mart oyida Incyte Corporation nomini olgan. Incyte Corporation 1991 yilda tashkil etilgan va shtab-kvartirasi Uilmington, Delaver shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Pablo J. Cagnoni M.D., Ph.D. | President and Global Head of Research & Development |
| Dr. Steven H. Stein M.D. | Executive VP, Head of Late-stage Development & Chief Medical Officer |
| Mr. Michael James Morrissey | Executive VP & Head of Global Technical Operations |
| Mr. Mohamed Khairie Issa | Executive Vice President & Head of U.S. Commercial |
| Mr. Richard A. Hoffman J.D., M.B.A. | Executive VP & General Counsel |
| Mr. Suketu P. Upadhyay |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-28 | DEFA14A | a2026incytenoticeaccess.htm |
| 2026-04-28 | 8-K | incy-20260428.htm |
| 2026-03-30 | 8-K | incy-20260326.htm |
| 2026-03-26 | 8-K | incy-20260325.htm |
| 2026-03-06 | 8-K | incy-20260227.htm |
| 2026-02-10 | 8-K | incy-20260210.htm |
| 2025-12-12 | 8-K | incy-20251210.htm |
| 2025-10-28 | 8-K | incy-20251028.htm |
| 2025-10-28 | 10-Q | incy-20250930.htm |
| 2025-10-03 | 8-K | tm2527974d1_8k.htm |
| Executive VP & CFO |
| Mr. Thomas Tray | Principal Financial Officer, VP of Finance & Chief Accounting Officer |
| Mr. William J. Meury | CEO & Director |
| Ms. Alexis Smith | Vice President & Head of Investor Relations |
| Ms. Pamela M. Murphy | Vice President of Investor Relations & Corporate Communications |